These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22619995)

  • 1. [Research and development for cancer biomarker].
    Nakagawa H
    Nihon Rinsho; 2012 May; 70(5):743-7. PubMed ID: 22619995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translational crossroads for biomarkers.
    Bast RC; Lilja H; Urban N; Rimm DL; Fritsche H; Gray J; Veltri R; Klee G; Allen A; Kim N; Gutman S; Rubin MA; Hruszkewycz A
    Clin Cancer Res; 2005 Sep; 11(17):6103-8. PubMed ID: 16144908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized medicine: marking a new epoch in cancer patient management.
    Diamandis M; White NM; Yousef GM
    Mol Cancer Res; 2010 Sep; 8(9):1175-87. PubMed ID: 20693306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of molecular biomarkers in individualized treatment of colorectal cancer.
    De Mattos-Arruda L; Dienstmann R; Tabernero J
    Clin Colorectal Cancer; 2011 Dec; 10(4):279-89. PubMed ID: 21729679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic approaches in lung cancer biomarker development.
    Cho JY; Sung HJ
    Expert Rev Proteomics; 2009 Feb; 6(1):27-42. PubMed ID: 19210125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological markers in lung cancer: A clinician's perspective.
    Tufman A; Huber RM
    Cancer Biomark; 2010; 6(3-4):123-35. PubMed ID: 20660959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proteomics for biomarker development toward personalized medicine].
    Kondo T
    Rinsho Byori; 2012 Jul; 60(7):644-9. PubMed ID: 22973724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification, validation, and clinical implementation of tumor-associated biomarkers to improve therapy concepts, survival, and quality of life of cancer patients: tasks of the Receptor and Biomarker Group of the European Organization for Research and Treatment of Cancer.
    Schmitt M; Harbeck N; Daidone MG; Brynner N; Duffy MJ; Foekens JA; Sweep FC
    Int J Oncol; 2004 Nov; 25(5):1397-406. PubMed ID: 15492831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics.
    Parkinson DR; Johnson BE; Sledge GW
    Clin Cancer Res; 2012 Feb; 18(3):619-24. PubMed ID: 22298894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum cancer biomarker discovery through analysis of gene expression data sets across multiple tumor and normal tissues.
    Jin H; Lee HC; Park SS; Jeong YS; Kim SY
    J Biomed Inform; 2011 Dec; 44(6):1076-85. PubMed ID: 21872680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian cancer biomarkers for molecular biosensors and translational medicine.
    Suh KS; Park SW; Castro A; Patel H; Blake P; Liang M; Goy A
    Expert Rev Mol Diagn; 2010 Nov; 10(8):1069-83. PubMed ID: 21080822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics strategies for translating genome-wide expression analyses into clinically useful cancer markers.
    Rhodes DR; Chinnaiyan AM
    Ann N Y Acad Sci; 2004 May; 1020():32-40. PubMed ID: 15208181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Drug Development: New Targets for Cancer Treatment.
    Curt GA
    Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New science-based endpoints to accelerate oncology drug development.
    Kelloff GJ; Sigman CC
    Eur J Cancer; 2005 Mar; 41(4):491-501. PubMed ID: 15737552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers in veterinary cancer screening: Applications, limitations and expectations.
    Henry CJ
    Vet J; 2010 Jul; 185(1):10-4. PubMed ID: 20510636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of biomarkers for molecular target drugs].
    Saijo K; Ishioka C
    Nihon Rinsho; 2015 Aug; 73(8):1308-12. PubMed ID: 26281683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.